Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Legal Names
Legal name
Similar Companies1000
Sio Gene Therapies
Sio Gene Therapies is a clinical-stage biopharmaceutical company focused on gene therapy for neurodegenerative diseases.
Sector
Subsector
Location
total rounds
total raised
Abeona Therapeutics
Abeona Therapeutics is developing gene therapies and plasma-based products for life-threatening rare genetic diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Avrobio
Avrobio is a clinical-stage gene therapy company developing advanced treatments for cancer and rare diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Gemini Therapeutics
Gemini Therapeutics is developing therapeutics for genetically-defined dry age-related macular degeneration (AMD).
Sector
Subsector
Location
total rounds
total raised
M&A Details1
Financials
Funding Rounds5
Number of Funding Rounds
Money Raised
Their latest funding was raised on 28.09.2017. Their latest round Post-IPO Equity
Wellington Management
Wellington Management manages over $1 trillion for clients in 60 countries.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Syncona Partners LLP
Syncona Partners LLP is a healthcare company that invests in and builds global leaders in life science.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Redmile Group
Redmile Group is a San Francisco-based healthcare investment company.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Syncona Partners LLP
Syncona Partners LLP is a healthcare company that invests in and builds global leaders in life science.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
New Enterprise Associates
NEA is a global venture capital firm that helps entrepreneurs build innovative businesses in technology and healthcare.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors4
Number of lead investors
Number of investors
Syncona Partners LLP
Syncona Partners LLP is a healthcare company that invests in and builds global leaders in life science.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Wellington Management
Wellington Management manages over $1 trillion for clients in 60 countries.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Redmile Group
Redmile Group is a San Francisco-based healthcare investment company.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders1
Matthew J. During
Dr. During is a MIT, Harvard and Yale-trained MD/PhD neuroscientist. He served nine years on faculty of Yale University as Professor of Neurosurgery. Subsequently, Dr. During served as a Professor at Cornell and Ohio State Universities for ten years. Since 2011, he has served as a visiting Professor of Translational Neuroscience at the University of Oxford. Dr. During pioneered the use of viral vectors for neurological disorders, and was the first to carry out gene transfer into the brain of a pediatric patient. He was the Principal Investigator and the FDA sponsor for two pioneering gene therapy studies, including the first and only successful Phase 2 trial of a biological therapy for Parkinson’s disease. He has published over 225 articles, with many in the world’s most prestigious journals including Nature, Science, Cell, Nature Medicine, Nature Genetics, the Lancet and Science Translational Medicine. He is the inventor on over 50 patents and patent applications. In addition, Dr. During has won many awards including the American Epilepsy Society Young Investigator of the Year, Roche Translational Neuroscience Award, Johnson and Johnson Focused Giving Award, BMS Neuroscience Award, and Nancy Sirrett and Keith Harrison Awards. He is a Fellow of the American College of Physicians, the Australasian College of Physicians, and a Fellow of the American Association for the Advancement of Science. He previously co-founded Merlin Pharmaceuticals, Neurologix and NightstaRx.
current job
organization founded
Matthew J. During